Eslicarbazepine Acetate and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Eslicarbazepine Acetate and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eslicarbazepine
Brand name: Aptiom
Synonyms: Eslicarbazepine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eslicarbazepine Acetate-Insulin degludec
- Eslicarbazepine Acetate-Insulin Degludec (U-100) Prefilled Pens
- Eslicarbazepine Acetate-Insulin Degludec (U-100) Vials
- Eslicarbazepine Acetate-Insulin Degludec (U-200) Prefilled Pens
- Eslicarbazepine Acetate-Insulin degludec and liraglutide
- Eslicarbazepine Acetate-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Esmolol
- Insulin aspart, recombinant Subcutaneous-Esmolol HCl
- Insulin aspart, recombinant Subcutaneous-Esmolol Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Esmolol Injection
- Insulin aspart, recombinant Subcutaneous-Esmolol Intravenous
- Insulin aspart, recombinant Subcutaneous-Esomep-EZS